Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease

Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: V...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/22717
Acceso en línea:
https://doi.org/10.1080/09273948.2017.1320411
https://repository.urosario.edu.co/handle/10336/22717
Palabra clave:
Cyclosporine
Dexamethasone
Folic acid
Methotrexate
Prednisone
Adult
Aged
Anterior eye chamber
Antiangiogenic activity
Arm
Article
B scan
Best corrected visual acuity
Bilateral iris depigmentation
Biomicroscopy
Case report
Cataract
Cataract extraction
Ciliary body
Clinical article
Clinical feature
Clinical outcome
Consultation
Cornea
Depigmentation
Diagnostic test
Disease duration
Disease severity
Drug dose escalation
Early diagnosis
Eye examination
Eye fundus
Eyelid
Female
Granulomatosis
Hand
Health service
Hospital admission
Human
Immunosuppressive treatment
Intraocular hypertension
Intraocular hypotension
Intraocular pressure
Iris atrophy
Iris disease
Lens implantation
Macular edema
Male
Medical history
Middle aged
Multiple cycle treatment
Neck
Optical coherence tomography
Patient referral
Pterygium
Recurrent disease
Retina detachment
Retina fluorescein angiography
Retina macula cystoid edema
Slit lamp microscopy
Transillumination
Treatment indication
Uveitis
Visual acuity
Vitiligo
Vitrectomy
Vitreous opacity
Vogt koyanagi syndrome
Atrophy
Hypopigmentation
Intraocular hypotension
Iris
Iris disease
Meningoencephalitis
Pathology
Pigment epithelium
Slit lamp
Adult
Aged
Atrophy
Female
Humans
Hypopigmentation
Iris
Iris diseases
Male
Middle aged
Ocular hypotension
Pigment epithelium of eye
Slit lamp
Uveomeningoencephalitic syndrome
Iris atrophy
Iris depigmentation
Ocular hypotony
Panuveitis
Vkh
Vogt–koyanagi–harada disease
optical coherence
Tomography
Rights
License
Abierto (Texto Completo)
id EDOCUR2_5aa448b54e3f23175edba31923ee3d46
oai_identifier_str oai:repository.urosario.edu.co:10336/22717
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 075cd1f5-fe86-43f9-a84c-1c1bc5c10bd85170135560075481961-d9f8-49a2-9cbb-91c08a431bd92020-05-25T23:57:40Z2020-05-25T23:57:40Z2018Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop. ©, © Taylor and Francis Group, LLC.application/pdfhttps://doi.org/10.1080/09273948.2017.13204119273948https://repository.urosario.edu.co/handle/10336/22717engTaylor and Francis Ltd1106No. 71101Ocular Immunology and InflammationVol. 26Ocular Immunology and Inflammation, ISSN:9273948, Vol.26, No.7 (2018); pp. 1101-1106https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019707641&doi=10.1080%2f09273948.2017.1320411&partnerID=40&md5=006a9f59c57db046fdb6b370caf7af91Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURCyclosporineDexamethasoneFolic acidMethotrexatePrednisoneAdultAgedAnterior eye chamberAntiangiogenic activityArmArticleB scanBest corrected visual acuityBilateral iris depigmentationBiomicroscopyCase reportCataractCataract extractionCiliary bodyClinical articleClinical featureClinical outcomeConsultationCorneaDepigmentationDiagnostic testDisease durationDisease severityDrug dose escalationEarly diagnosisEye examinationEye fundusEyelidFemaleGranulomatosisHandHealth serviceHospital admissionHumanImmunosuppressive treatmentIntraocular hypertensionIntraocular hypotensionIntraocular pressureIris atrophyIris diseaseLens implantationMacular edemaMaleMedical historyMiddle agedMultiple cycle treatmentNeckOptical coherence tomographyPatient referralPterygiumRecurrent diseaseRetina detachmentRetina fluorescein angiographyRetina macula cystoid edemaSlit lamp microscopyTransilluminationTreatment indicationUveitisVisual acuityVitiligoVitrectomyVitreous opacityVogt koyanagi syndromeAtrophyHypopigmentationIntraocular hypotensionIrisIris diseaseMeningoencephalitisPathologyPigment epitheliumSlit lampAdultAgedAtrophyFemaleHumansHypopigmentationIrisIris diseasesMaleMiddle agedOcular hypotensionPigment epithelium of eyeSlit lampUveomeningoencephalitic syndromeIris atrophyIris depigmentationOcular hypotonyPanuveitisVkhVogt–koyanagi–harada diseaseoptical coherenceTomographyBilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada DiseasearticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Cuevas M.de-la-Torre, AlejandraCórdoba A.10336/22717oai:repository.urosario.edu.co:10336/227172022-05-02 07:37:15.943908https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease
title Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease
spellingShingle Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease
Cyclosporine
Dexamethasone
Folic acid
Methotrexate
Prednisone
Adult
Aged
Anterior eye chamber
Antiangiogenic activity
Arm
Article
B scan
Best corrected visual acuity
Bilateral iris depigmentation
Biomicroscopy
Case report
Cataract
Cataract extraction
Ciliary body
Clinical article
Clinical feature
Clinical outcome
Consultation
Cornea
Depigmentation
Diagnostic test
Disease duration
Disease severity
Drug dose escalation
Early diagnosis
Eye examination
Eye fundus
Eyelid
Female
Granulomatosis
Hand
Health service
Hospital admission
Human
Immunosuppressive treatment
Intraocular hypertension
Intraocular hypotension
Intraocular pressure
Iris atrophy
Iris disease
Lens implantation
Macular edema
Male
Medical history
Middle aged
Multiple cycle treatment
Neck
Optical coherence tomography
Patient referral
Pterygium
Recurrent disease
Retina detachment
Retina fluorescein angiography
Retina macula cystoid edema
Slit lamp microscopy
Transillumination
Treatment indication
Uveitis
Visual acuity
Vitiligo
Vitrectomy
Vitreous opacity
Vogt koyanagi syndrome
Atrophy
Hypopigmentation
Intraocular hypotension
Iris
Iris disease
Meningoencephalitis
Pathology
Pigment epithelium
Slit lamp
Adult
Aged
Atrophy
Female
Humans
Hypopigmentation
Iris
Iris diseases
Male
Middle aged
Ocular hypotension
Pigment epithelium of eye
Slit lamp
Uveomeningoencephalitic syndrome
Iris atrophy
Iris depigmentation
Ocular hypotony
Panuveitis
Vkh
Vogt–koyanagi–harada disease
optical coherence
Tomography
title_short Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease
title_full Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease
title_fullStr Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease
title_full_unstemmed Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease
title_sort Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt–Koyanagi–Harada Disease
dc.subject.keyword.spa.fl_str_mv Cyclosporine
Dexamethasone
Folic acid
Methotrexate
Prednisone
Adult
Aged
Anterior eye chamber
Antiangiogenic activity
Arm
Article
B scan
Best corrected visual acuity
Bilateral iris depigmentation
Biomicroscopy
Case report
Cataract
Cataract extraction
Ciliary body
Clinical article
Clinical feature
Clinical outcome
Consultation
Cornea
Depigmentation
Diagnostic test
Disease duration
Disease severity
Drug dose escalation
Early diagnosis
Eye examination
Eye fundus
Eyelid
Female
Granulomatosis
Hand
Health service
Hospital admission
Human
Immunosuppressive treatment
Intraocular hypertension
Intraocular hypotension
Intraocular pressure
Iris atrophy
Iris disease
Lens implantation
Macular edema
Male
Medical history
Middle aged
Multiple cycle treatment
Neck
Optical coherence tomography
Patient referral
Pterygium
Recurrent disease
Retina detachment
Retina fluorescein angiography
Retina macula cystoid edema
Slit lamp microscopy
Transillumination
Treatment indication
Uveitis
Visual acuity
Vitiligo
Vitrectomy
Vitreous opacity
Vogt koyanagi syndrome
Atrophy
Hypopigmentation
Intraocular hypotension
Iris
Iris disease
Meningoencephalitis
Pathology
Pigment epithelium
Slit lamp
Adult
Aged
Atrophy
Female
Humans
Hypopigmentation
Iris
Iris diseases
Male
Middle aged
Ocular hypotension
Pigment epithelium of eye
Slit lamp
Uveomeningoencephalitic syndrome
Iris atrophy
Iris depigmentation
Ocular hypotony
Panuveitis
Vkh
Vogt–koyanagi–harada disease
topic Cyclosporine
Dexamethasone
Folic acid
Methotrexate
Prednisone
Adult
Aged
Anterior eye chamber
Antiangiogenic activity
Arm
Article
B scan
Best corrected visual acuity
Bilateral iris depigmentation
Biomicroscopy
Case report
Cataract
Cataract extraction
Ciliary body
Clinical article
Clinical feature
Clinical outcome
Consultation
Cornea
Depigmentation
Diagnostic test
Disease duration
Disease severity
Drug dose escalation
Early diagnosis
Eye examination
Eye fundus
Eyelid
Female
Granulomatosis
Hand
Health service
Hospital admission
Human
Immunosuppressive treatment
Intraocular hypertension
Intraocular hypotension
Intraocular pressure
Iris atrophy
Iris disease
Lens implantation
Macular edema
Male
Medical history
Middle aged
Multiple cycle treatment
Neck
Optical coherence tomography
Patient referral
Pterygium
Recurrent disease
Retina detachment
Retina fluorescein angiography
Retina macula cystoid edema
Slit lamp microscopy
Transillumination
Treatment indication
Uveitis
Visual acuity
Vitiligo
Vitrectomy
Vitreous opacity
Vogt koyanagi syndrome
Atrophy
Hypopigmentation
Intraocular hypotension
Iris
Iris disease
Meningoencephalitis
Pathology
Pigment epithelium
Slit lamp
Adult
Aged
Atrophy
Female
Humans
Hypopigmentation
Iris
Iris diseases
Male
Middle aged
Ocular hypotension
Pigment epithelium of eye
Slit lamp
Uveomeningoencephalitic syndrome
Iris atrophy
Iris depigmentation
Ocular hypotony
Panuveitis
Vkh
Vogt–koyanagi–harada disease
optical coherence
Tomography
dc.subject.keyword.eng.fl_str_mv optical coherence
Tomography
description Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop. ©, © Taylor and Francis Group, LLC.
publishDate 2018
dc.date.created.spa.fl_str_mv 2018
dc.date.accessioned.none.fl_str_mv 2020-05-25T23:57:40Z
dc.date.available.none.fl_str_mv 2020-05-25T23:57:40Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1080/09273948.2017.1320411
dc.identifier.issn.none.fl_str_mv 9273948
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/22717
url https://doi.org/10.1080/09273948.2017.1320411
https://repository.urosario.edu.co/handle/10336/22717
identifier_str_mv 9273948
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 1106
dc.relation.citationIssue.none.fl_str_mv No. 7
dc.relation.citationStartPage.none.fl_str_mv 1101
dc.relation.citationTitle.none.fl_str_mv Ocular Immunology and Inflammation
dc.relation.citationVolume.none.fl_str_mv Vol. 26
dc.relation.ispartof.spa.fl_str_mv Ocular Immunology and Inflammation, ISSN:9273948, Vol.26, No.7 (2018); pp. 1101-1106
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019707641&doi=10.1080%2f09273948.2017.1320411&partnerID=40&md5=006a9f59c57db046fdb6b370caf7af91
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Taylor and Francis Ltd
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167590678822912